Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
Hongjie YuZhuqing ShiYishuo WuChi-Hsiung WangXiaoling LinChelsea PerschonWilliam B IsaacsBrian T HelfandS Lilly ZhengDavid DugganZengnan MoDaru LuJianfeng XuPublished in: The Prostate (2019)
Performance differed considerably among GRS tests. We recommend that all GRS tests be evaluated using the two benchmarks before clinical implementation for individual risk assessment.